SCHEMBL13862215

SCHEMBL13862215

O=Cc1cn(CCO)c2cc(F)c(Cc3cccc(Cl)c3F)cc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ HTT P42858 5/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ METTL3 Q86U44 1/20 0.41
▸ CFD P00746 4/20 0.36
▸ LMNA P02545 4/20 0.36
▸ TDP1 Q9NUW8 2/20 0.33
▸ SLC22A12 Q96S37 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ RCE1 Q9Y256 1/20 0.32
▸ PCSK9 Q8NBP7 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ PTPN1 P18031 1/20 0.30
▸ P2RX7 Q99572 1/20 0.30
▸ MPO P05164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12957421 0.88 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL11956919 0.86 METTL3 (0.43) METTL3CFDSLC22A12MAPTPCSK9
SCHEMBL11948595 0.84 METTL3 (0.54) ALDH1A1HTTMETTL3LMNAMAPT
SCHEMBL13251711 0.81 METTL3 (0.61) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL13607959 0.81 METTL3 (0.61) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL13862193 0.81 METTL3 (0.47) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL13862214 0.80 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL13862208 0.80 METTL3 (0.48) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL13862197 0.77 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL12957311 0.77 METTL3 (0.43) ALDH1A1METTL3TDP1MAPTP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
Send feedback